SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Buschke H, Kuslansky G, Katz M et al. Screening for dementia with the Memory Impairment Screen. Neurology 1999; 52: 231238.
  • 2
    Barker WW, Luis C, Harwood D et al. The effect of a memory screening program on the early diagnosis of Alzheimer disease. Alzheimer Dis Assoc Disord 2005; 19: 17.
  • 3
    Knopman DS. Current treatment of mild cognitive impairment and Alzheimer's disease. Curr Neurol Neurosci Rep 2006; 6: 365371.
  • 4
    Bennett DA, Schneider JA, Arvanitakis Z et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006; 66: 18371844.
  • 5
    Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 13561364.
  • 6
    Stern RG, Mohs RC, Davidson M et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994; 151: 390396.
  • 7
    Rozzini L, Vicini Chilovi B, Bertoletti E et al. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. J Geriatr Psychiatry Neurol 2008; 21: 261267.
  • 8
    Wang BS, Wang H, Song YY et al. Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis. Pharmacopsychiatry 2010; 43 (3): 8691.
  • 9
    Hayes TL, Larimer N, Adami A, Kaye JA. Medication adherence in healthy elders: small cognitive changes make a big difference. J Aging Health 2009; 21: 567580.
  • 10
    Rockwood K, Fay S, Gorman M, Carver D, Graham JE. The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial. BMC Neurol 2007; 7: 26.
  • 11
    Aguirre E, Spector A, Hoe J et al. Maintenance Cognitive Stimulation Therapy (CST) for dementia: a single-blind, multi-centre, randomized controlled trial of Maintenance CST vs. CST for dementia. Trials 2010; 11: 46.
  • 12
    Lautenschlager NT, Cox KL, Flicker L et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008; 300: 10271037.
  • 13
    Benge JF, Balsis S, Geraci L, Massman PJ, Doody RS. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease? Dement Geriatr Cogn Disord 2009; 28: 6369.
  • 14
    Wouters H, van Gool WA, Schmand B, Lindeboom R. Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Dis Assoc Disord 2008; 22: 236244.
  • 15
    McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939944.
  • 16
    Brown J, Pengas G, Dawson K, Brown LA, Clatworthy P. Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ 2009; 338: b2030.
  • 17
    Fong TG, Fearing MA, Jones RN et al. Telephone interview for cognitive status: creating a crosswalk with the Mini-Mental State Examination. Alzheimers Dement 2009; 5: 492497.
  • 18
    Maki Y, Yoshida H, Yamaguchi H. Computerized visuo-spatial memory test as a supplementary screening test for dementia. Psychogeriatrics 2010; 10: 7782.
  • 19
    Inoue M, Jinbo D, Nakamura Y, Taniguchi M, Urakami K. Development and evaluation of a computerized test battery for Alzheimer's disease screening in community-based settings. Am J Alzheimers Dis Other Demen 2009; 24: 129135.
  • 20
    Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol 2006; 21: 623643.
  • 21
    Martini L, Domahs F, Benke T, Delazer M. Everyday numerical abilities in Alzheimer's disease. J Int Neuropsychol Soc 2003; 9: 871878.
  • 22
    Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL. The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. J Am Geriatr Soc 1992; 40: 579584.